Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$96.34 - $112.38 $6.1 Million - $7.12 Million
-63,351 Reduced 9.82%
581,947 $59.9 Million
Q1 2023

May 15, 2023

BUY
$107.32 - $113.5 $14.3 Million - $15.1 Million
133,000 Added 25.96%
645,298 $70.4 Million
Q4 2022

Feb 14, 2023

BUY
$62.39 - $113.8 $32 Million - $58.3 Million
512,298 New
512,298 $58.3 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $535,804 - $680,822
-6,200 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $611,072 - $743,442
6,200 New
6,200 $668,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Highland Capital Management Fund Advisors, L.P. Portfolio

Follow Highland Capital Management Fund Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Capital Management Fund Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highland Capital Management Fund Advisors, L.P. with notifications on news.